Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

PubMed Links for Books (Select 1657890)

1.

Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines.

Li Q, Anver MR, Butcher DO, Gildersleeve JC.

Mol Cancer Ther. 2009 Apr;8(4):971-9. doi: 10.1158/1535-7163.MCT-08-0934.

2.

Mouse-human chimeric anti-Tn IgG1 induced anti-tumor activity against Jurkat cells in vitro and in vivo.

Ando H, Matsushita T, Wakitani M, Sato T, Kodama-Nishida S, Shibata K, Shitara K, Ohta S.

Biol Pharm Bull. 2008 Sep;31(9):1739-44.

3.

Structural basis for recognition of breast and colon cancer epitopes Tn antigen and Forssman disaccharide by Helix pomatia lectin.

Lescar J, Sanchez JF, Audfray A, Coll JL, Breton C, Mitchell EP, Imberty A.

Glycobiology. 2007 Oct;17(10):1077-83. Epub 2007 Jul 25.

4.

Structural basis for the specificity of basic winged bean lectin for the Tn-antigen: a crystallographic, thermodynamic and modelling study.

Kulkarni KA, Sinha S, Katiyar S, Surolia A, Vijayan M, Suguna K.

FEBS Lett. 2005 Dec 19;579(30):6775-80. Epub 2005 Nov 21. Erratum in: FEBS Lett. 2006 May 15;580(11):2808.

5.

IgG immune response to tumor-associated carbohydrate antigens (TF, Tn, alphaGal) in patients with breast cancer: impact of neoadjuvant chemotherapy and relation to the survival.

Kurtenkov O, Klaamas K, Rittenhouse-Olson K, Vahter L, Sergejev B, Miljukhina L, Shljapnikova L.

Exp Oncol. 2005 Jun;27(2):136-40.

PMID:
15995632
6.

Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.

Slovin SF, Ragupathi G, Musselli C, Olkiewicz K, Verbel D, Kuduk SD, Schwarz JB, Sames D, Danishefsky S, Livingston PO, Scher HI.

J Clin Oncol. 2003 Dec 1;21(23):4292-8.

PMID:
14645418
7.
8.
9.

Novel Tn antigen-containing neoglycopeptides: synthesis and evaluation as anti tumor vaccines.

Cipolla L, Rescigno M, Leone A, Peri F, La Ferla B, Nicotra F.

Bioorg Med Chem. 2002 May;10(5):1639-46.

PMID:
11886825
10.

Production and functional characterization of two mouse/human chimeric antibodies with specificity for the tumor-associated Tn-antigen.

Oppezzo P, Osinaga E, Tello D, Bay S, Cantacuzene D, IrigoĆ­n F, Ferreira A, Roseto A, Cayota A, Alzari P, Pritsch O.

Hybridoma. 2000 Jun;19(3):229-39.

PMID:
10952411
11.

Tn antigen is a pre-cancerous biomarker in breast tissue and serum in n-nitrosomethylurea-induced rat mammary carcinogenesis.

Babino A, Oppezzo P, Bianco S, Barrios E, Berois N, Navarrete H, Osinaga E.

Int J Cancer. 2000 Jun 15;86(6):753-9.

PMID:
10842187
12.

Increased streptavidin uptake in tumors pretargeted with biotinylated antibody using a conjugate of streptavidin-fab fragment.

Yao Z, Zhang M, Sakahara H, Saga T, Kobayashi H, Nakamoto Y, Toyama S, Konishi J.

Nucl Med Biol. 1998 Aug;25(6):557-60.

PMID:
9751423
13.

Effect of administration route and dose of streptavidin or biotin on the tumor uptake of radioactivity in intraperitoneal tumor with multistep targeting.

Zhang M, Yao Z, Sakahara H, Saga T, Nakamoto Y, Sato N, Zhao S, Nakada H, Yamashina I, Konishi J.

Nucl Med Biol. 1998 Feb;25(2):101-5.

PMID:
9468023
14.

Three-step tumor imaging with biotinylated monoclonal antibody, streptavidin and 111In-DTPA-biotin.

Nakamoto Y, Saga T, Sakahara H, Yao Z, Zhang M, Sato N, Zhao S, Nakada H, Yamashina I, Konishi J.

Nucl Med Biol. 1998 Feb;25(2):95-9.

PMID:
9468022
15.

Improved intratumoral penetration of radiolabeled streptavidin in intraperitoneal tumors pretargeted with biotinylated antibody.

Zhang M, Yao Z, Saga T, Sakahara H, Nakamoto Y, Sato N, Nakada H, Yamashina I, Konishi J.

J Nucl Med. 1998 Jan;39(1):30-3.

16.

Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy.

Springer GF.

J Mol Med (Berl). 1997 Aug;75(8):594-602. Review.

PMID:
9297627
17.

Intravenous avidin chase improved localization of radiolabeled streptavidin in intraperitoneal xenograft pretargeted with biotinylated antibody.

Zhang M, Sakahara H, Yao Z, Saga T, Nakamoto Y, Sato N, Nakada H, Yamashina I, Konishi J.

Nucl Med Biol. 1997 Jan;24(1):61-4.

PMID:
9080476
18.

Radioimmunoimaging of colon cancer xenografts with anti-Tn monoclonal antibody.

Yao Z, Sakahara H, Zhang M, Kobayashi H, Nakada H, Yamashina I, Konishi J.

Nucl Med Biol. 1995 Feb;22(2):199-203.

PMID:
7767313
19.

Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase.

Yao Z, Zhang M, Kobayashi H, Sakahara H, Nakada H, Yamashina I, Konishi J.

J Nucl Med. 1995 May;36(5):837-41.

20.

T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced breast carcinoma.

Springer GF, Desai PR, Spencer BD, Tegtmeyer H, Carlstedt SC, Scanlon EF.

Cancer Detect Prev. 1995;19(4):374-80.

PMID:
7553680
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk